Germany goes global in battle against COVID-19
The Erlangen-based company Siemens Healthineers of Erlangen has announced it is shipping its test for SARS-CoV-2 antibodies around the world. The antibody test allows for identification of patients who have developed an adaptive immune response to the virus.
Siemens says the test has shown 100 percent sensitivity and 99.8 percent specificity in identifying SARS-CoV-2 antibodies. The kits have been approved by regulators in the European Union and the US. The company says that Siemens laboratory systems – of which there are 20 thousand installed worldwide – can process between 240 and 440 tests an hour, depending on the type of analyzer. What is more, Healthineers says it is able to increase production capacity to more than 50 million antibody tests per month.
The president of Laboratory Diagnostics at Siemens Healthineers, Deepak Nath, explained, “Not all antibody tests are created equal. A high-quality test that targets the right protein and is highly scalable is essential for antibody testing to help ensure we effectively manage the threat of COVID-19. Siemens Healthineers sought to provide a highly accurate antibody test that could reach millions of people to address the current need for identifying immune response, and also for delivering long-term value as we look toward immunity and vaccination.”
Siemens Healthineers is a leading global medical technology company. Among its specialities are innovative diagnostic and therapeutic imaging technologies, laboratory diagnostics, molecular medicine, and digital health. The company has more than 120 years of experience in 18,500 global patents.
Siemens Healthineers contribution to the fight against COVID-19 is just one example of Germany’s excellence in healthcare and medical technology in particular. The export initiative for the German healthcare industry, HEALTH MADE IN GERMANY, is the go-to place learn more about cooperation and doing business with one of the most dynamic sectors of the German economy.